|
[1]KANG FL, ZHANG YX.Research advances in liver cirrhosis complicated by portal vein thrombosis[J].J Clin Hepatol, 2016, 32 (8) :1608-1612. (in Chinese) 康福来, 张跃新.肝硬化并发门静脉血栓的研究进展[J].临床肝胆病杂志, 2016, 32 (8) :1608-1612.
|
|
[2]GULBINS E.Regulation of death receptor signaling and apoptosis by ceramide[J].Pharmacol Res, 2003, 47 (5) :393-399.
|
|
[3]UEDA N.Sphingolipids in genetic and acquired forms of chronic kidney diseases[J].Curr Med Chem, 2017.[Epub ahead of print]
|
|
[4]SOBEL K, MENYHART K, KILLER N, et al.Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling[J].J Biol Chem, 2013, 288 (21) :14839-14851.
|
|
[5]ZHANG J, BANG A, LYE SJ.Analysis of S1P receptor expression by uterine immune cells using standardized multi-parametric flow cytometry[J].Methods Mol Biol, 2017.[Epub ahead of print]
|
|
[6]SHEA BS, TAGER AM.Sphingolipid regulation of tissue fibrosis[J].Open Rheumatol J, 2012, 6 (1) :123-129.
|
|
[7]CHANG HC, HSU C, HSU HK, et al.Functional role of caspases in sphingosine-induced apoptosis in human hepatoma cells[J].IUBMBLife, 2003, 55 (7) :403-407.
|
|
[8]MACEYKA M, SANKALA H, HAIT NC, et al.Sph K1 and Sph K2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism[J].J Biol Chem, 2005, 280 (44) :37118-37129.
|
|
[9]ALEMANY R, van KOPPEN CJ, DANNEBERG K, et al.Regulation and functional roles of sphingosine kinases[J].Naunyn Schmiedebergs Arch Pharmacol, 2007, 374 (5) :413-428.
|
|
[10]LIU H, SUGIURA M, NAVA VE, et al.Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform[J].J Biol Chem, 2000, 275 (26) :19513-19520.
|
|
[11]HANNUN YA, OBEID LM.Principles of bioactive lipid signalling:lessons from sphingolipids[J].Nat Rev Mol Cell Biol, 2008, 9 (2) :139-150.
|
|
[12]SPIEGEL S, MILSTIEN S.Sphingosine-1-phosphate:an enigmatic signalling lipid[J].Nat Rev Mol Cell Biol, 2003, 4 (5) :397-407.
|
|
[13]GELLINGS LN, SWANEY JS, MORENO KM, et al.Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts[J].Cardiovasc Res, 2009, 82 (2) :303-312.
|
|
[14]LEE SY, KIM DH, SUNG SA, et al.Sphingosine-1-phosphate reduces hepatic ischaemia/reper-fusion-induced acute kidney injury through attenuation of endothelial injury in mice[J].Nephrology, 2011, 16 (2) :163-173.
|
|
[15]ZHAO Y, GORSHKOVA IA, BERDYSHEV E, et al.Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression[J].Am J Respir Cell Mol Biol, 2011, 45 (2) :426-435.
|
|
[16]LIU X, YUE S, LI C, et al.Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation[J].J Cell Physiol, 2011, 226 (9) :2370-2377.
|
|
[17]MEYER ZU HERINGDORF D, JAKOBS KH.Lysophospholipid receptors:signalling, pharmacology and regulation by lysophospholipid metabolism[J].Biochim Biophys Acta, 2007, 1768 (4) :923-940.
|
|
[18]XIN C, REN S, KLEUSER B, et al.Sphingosine-1-phosphate cross-activates the Smad signaling cascade and mimics TGF betainduced cell responses[J].J Biol Chem, 2004, 279 (34) :35255-35262.
|
|
[19]PROIA RL, HLA T.Emerging biology of sphingosine-1-phosphate:its role in pathogenesis and therapy[J].J Clin Invest, 2015, 125 (4) :1379-1387.
|
|
[20]MOUSSEAU Y, MOLLARD S, RICHARD L, et al.Fingolimod inhibits PDGF-B-induced migration of vascular smooth muscle cell by down-regulating the S1PR1/S1PR3 pathway.[J].Biochimie, 2012, 94 (12) :2523-2531.
|
|
[21]THOMAS K, SEHR T, PROSCHMANN U, et al.Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation[J].JNeuroinflammation, 2017, 14 (1) :41.
|
|
[22]PATMANATHAN SN, WEI W, YAP LF, et al.Mechanisms of sphingosine 1-phosphate receptor signalling in cancer[J].Cell Signal, 2017, 34:66-75.
|
|
[23]YOSHIMURA A, WAKABAYASHI Y, MORI T.Cellular and molecular basis for the regulation of inflammation by TGF-beta[J].JBiochem, 2010, 147 (6) :781-792.
|
|
[24]BONNER JC.Regulation of PDGF and its receptors in fibrotic diseases[J].Cytokine Growth Factor Rev, 2004, 15 (4) :255-273.
|
|
[25]REN S, BABELOVA A, MORETH K, et al.Transforming growth factor-β2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-β2 by impeding CTGF expression[J].Kidney International, 2009, 76 (8) :857-867.
|
|
[26]XIU L, CHANG N, YANG L, et al.Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors[J].Am J Pathol, 2014, 185 (2) :387-398.
|
|
[27]BORKHAM-KAMPHORST E, WEISKIRCHEN R.The PDGFsystem and its antagonists in liver fibrosis[J].Cytokine Growth Factor Rev, 2016, 28:53-61.
|
|
[28]KATSUMA S, SHIOJIMA S, HIRASAWA A, et al.Genomic analysis of a mouse model of immunoglobulin A nephropathy reveals an enhanced PDGF-EDG5 cascade[J].Pharmacogenomics J, 2001, 1 (3) :211-217.
|
|
[29]KATSUMA S, HADA Y, SHIOJIMA S, et al.Transcriptional profiling of gene expression patterns during sphingosine 1-phosphateinduced mesangial cell proliferation[J].Biochem Biophys Res Commun, 2003, 300 (2) :577-584.
|
|
[30]KING A, HOULIHAN DD, KAVANAGH D, et al.Sphingosine-1-phosphate prevents egress of hematopoietic stem cells from liver to reduce fibrosis[J].Gastroenterology, 2017.[Epub ahead of print]
|
|
[31]ZHANG CH, LI Y, CHEN W, et al.Protective effect of FTY720 on hepatic injury in experimental hepatic fibrosis mice[J].J Jilin Univ:Med Edit, 2015, 41 (6) :1154-1157. (in Chinese) 张宸豪, 李瑶, 陈为, 等.FTY720对实验性肝纤维化小鼠肝损伤的保护作用[J].吉林大学学报:医学版, 2015, 41 (6) :1154-1157.
|
|
[32]OO ML, THANGADA S, WU MT, et al.Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor[J].J Biol Chem, 2007, 282 (12) :9082-9089.
|
|
[33]AL FADEL F, FAYYAZ S, JAPTOK L, et al.Involvement of sphingosine 1-phosphate in palmitate-induced non-alcoholic fatty liver disease[J].Cell Physiol Biochem, 2016, 40 (6) :1637-1645.
|
|
[34]GELLINGS LN, SWANEY JS, MORENO KM, et al.Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts[J].Cardiovasc Res, 2009, 82 (2) :303.
|
|
[35]YANG L, HAN Z, TIAN L, et al.Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte/macrophage motility in cholestatic liver injury in mice[J].Sci Rep, 2015, 5:13423.
|
|
[36]YANG L, YUE S, YANG L, et al.Sphingosine kinase/sphingosine1-phosphate (S1P) /S1P receptor axis is involved in liver fibrosis-associated angiogenesis[J].J Hepatol, 2013, 59 (1) :114-123.
|
|
[37]LIU R, ZHAO R, ZHOU X, et al.Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2[J].Hepatology, 2014, 60 (3) :908-918.
|
|
[38]KARIMIAN G, BUIST-HOMAN M, SCHMIDT M, et al.Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile saltinduced apoptosis[J].Biochim Biophys Acta, 2013, 1832 (12) :1922-1929.
|
|
[39]GENG T, SUTTER A, HARLAND MD, et al.Sph K1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes[J].J Lipid Res, 2015, 56 (12) :2359-2371.
|
|
[40]LIU Y, SAIYAN S, MEN T, et al.Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine1-phosphate receptors[J].J Pathol, 2013, 230 (4) :365-376.
|
|
[41]GONZLEZ FERNNDEZ B, SNCHEZ DI, CRESPO I, et al.Inhibition of the Sph K1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells[J].Biofactors, 2017, 43 (2) :272-282.
|
|
[42]OKAMOTO H, TAKUWA N, YOKOMIZO T, et al.Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5but not EDG1 or EDG3[J].Mol Cell Biol, 2000, 20 (24) :9247-9261.
|
|
[43]WANG Y, AOKI H, YANG J, et al.The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice[J].Hepatology, 2017, 65 (6) :2005-2018.
|
|
[44]DING BS, LIU CH, SUN Y, et al.HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver[J].JCI Insight, 2016, 1 (21) :e87058.
|
|
[45]NAGAHASHI M, TAKABE K, LIU R, et al.Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2and hepatic gene expression[J].Hepatology, 2015, 61 (4) :1216-1226.
|
DownLoad: